Asia-Pacific Clinical Laboratory Services Market – Industry Trends and Forecast to 2030

아시아 태평양 임상실험실 서비스 시장 분석 및 규모

질병통제예방센터의 2020년 9월 보고서에 따르면, 민간인 비기관 성인의 약 51.8%(1억 2,900만 명)가 2018년에 선택된 10가지 만성 질환 중 하나 이상을 진단받았고, 성인의 24.6%(6,100만 명)가 만성 질환을 하나 앓고 있었고, 27.2%(6,800만 명)가 만성 질환을 두 개 이상 앓고 있어 미국 인구 중 만성 질환의 유병률이 높다는 것을 나타냅니다. 미국 내 주요 시장 참여자의 존재와 새로운 제품 혁신 및 출시가 미국의 임상 검사 서비스 시장 성장을 보완할 것으로 예상됩니다.

Data Bridge Market Research는 2022년에 2,104억 2,000만 달러였던 임상 검사 서비스 시장이 2030년까지 2,924억 3,000만 달러에 도달할 것으로 분석했으며, 2023년부터 2030년까지의 예측 기간 동안 4.2%의 CAGR을 기록할 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

아시아 태평양 임상 검사 서비스 시장 범위 및 세분화      

시장 정의

임상 검사실은 환자 진단, 예방, 치료 및 관리와 같은 광범위한 서비스를 제공하기 때문에 경제의 의료 시스템에 필수적입니다. 이러한 서비스는 의료 전문가가 개인의 필요와 질병에 따라 의학적 결정을 내리고 약물을 개인화하는 데 도움이 됩니다. 임상 검사실 서비스는 기술적으로 진보된 장치와 검사 키트를 사용하여 인적 오류를 줄이고 신뢰할 수 있는 결과를 제공합니다. 현재 여러 병원에서는 소프트웨어 프로그램과 컴퓨터를 활용하여 환자가 완료된 검사에 대한 결과 보고 및 청구에 대한 정보를 얻도록 돕고 있습니다.

임상실험실 서비스 시장 동향

운전자

• 전략적 파트너십 및 협력

The independent laboratories see significant consolidation as players focus on strategic partnerships and collaborations, which is expected to drive market growth. For instance, in October 2020, U-Diagnostics, a diagnostic laboratory in the Netherlands, partnered with CENTOGENE, a significant provider of COVID-19 testing in Germany, to expand COVID testing services throughout the Netherlands. Diaceutics PLC, a company focused on diagnostic network solutions for developing and commercializing precision medicine diagnostics, also patterned with Targos Molecular Pathology and HistoCyte Laboratories in July 2020 to enhance and expand diagnostic testing services in 2,500 labs worldwide. As a result, these developments fuel growth in both the studied segment and the overall clinical laboratory services market.

• Increase in geriatric population 

Life expectancy has increased significantly, particularly in developed countries, as access to better healthcare facilities and healthcare expenditures have increased. This has increased the global geriatric population. In 2010, the WHO estimated that 524 million people were 65 or older, accounting for 8% of the world's population. This figure is expected to triple by 2050, bringing the geriatric population to 1.5 billion, accounting for 16% of the global population. The increase in the geriatric population has increased in cases of age-related disorders. As a result, the number of clinical tests performed each year is increasing. People over the age of 50 are more vulnerable to diseases such as cancer, diabetes, and cardiovascular disease.

Opportunities

• Independent and reference laboratories is expected to register healthy growth

There is a huge opportunity for independent laboratories to thrive in the market in highly populated and developing countries like India and China, where a significant share of the population does not have access to proper medical diagnostic facilities, as they can fill the wide gap of clinical service providers in these regions, and thus the number of independent laboratories is increasing. According to the National Accreditation Board for Testing and Calibration Laboratories (NABL) of India, there were approximately 6,200 NABL accredited medical labs in India as of November 2020, which increased to 6,975 by March 2022 due to an increase in demand for these facilities throughout the country.

Restraints/Challenges

• Lack of diagnostic tests

Lack of diagnostic tests may potentially restrain the market progression during the forecast period. The regulatory framework for approvals has always been a major impediment to the pharmaceutical, biotechnology, and medical technology industries' growth rates.

This clinical laboratory services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical laboratory services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Clinical Laboratory Services Market

The COVID-19 pandemic had a moderate to high impact on the global market. COVID-19 infection has claimed the lives of millions of people worldwide in a very short period of time. Due to the sudden increase in cases of COVID-19 infection around the world, the pandemic raised awareness about the critical importance of clinical laboratory services. This has increased clinical laboratory services, particularly in the specialized chemistry testing segment. In order to keep up with suspected COVID-19 cases, industry demand for clinical laboratory testing has increased significantly and will continue to grow at a rapid pace.

Recent Developments

• In July 2021, Deep Bio, a pioneer in artificial intelligence (AI) cancer diagnostics, announced a research collaboration agreement with ARUP Laboratories, a leading U.S. reference laboratory and global leader in innovative laboratory research and development,. This collaboration has benefited the company in terms of using artificial intelligence in cancer diagnostics.
• In March 2022, Mindray introduced its latest BC-700 Series haematology analyzers for small-to-medium-sized labs, including complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.
• In September 2021, Roche Diagnostics' Indian division launched Cobas pure integrated solutions analyzer with a more intelligent system, which is especially suitable for the country's large number of labs and hospitals.

Asia-Pacific Clinical Laboratory Services Market Scope

The clinical laboratory services market is segmented on the basis of specialty, provider, application and service type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Specialty

• Clinical Chemistry Testing
• Hematology Testing
• Microbiology Testing
• Immunology Testing
• Drugs of Abuse Testing
• Cytology Testing and Genetic Testing

 Provider

• Independent and Reference Laboratories
• Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories

 Application

• Drug Discovery Related Services
• Drug Development Related Services
• Bioanalytical and Lab Chemistry Services
• Toxicology Testing Services
• Cell and Gene Therapy Related Services
• Preclinical and Clinical Trial Related Services
• Other Clinical Laboratory Services

 Service Type

• Routine Testing Services
• Esoteric Services and Anatomic Pathology Services

Clinical Laboratory Services Market Regional Analysis/Insights

The clinical laboratory services market is analyzed and market size insights and trends are provided by country, specialty, provider, application and service type as referenced above.

The countries covered in the clinical laboratory services market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is leading the growth of the market and routine testing services segment is dominating in this country due to rising demand for early and accurate disease diagnosis.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Clinical Laboratory Services Market Share Analysis

The clinical laboratory services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to clinical laboratory services market.

Some of the major players operating in the clinical laboratory services market are:

• Abbott (U.S.)
• ARUP Laboratories (U.S.)
• OPKO Health, Inc. (U.S.)
• Bioscientia Healthcare GmbH (Germany)
• Charles River Laboratories (U.S.)
• NeoGenomics Laboratories (U.S.)
• Genoptix, Inc. (U.S.)
• Healthscope (Australia)
• The Laboratory Glassware Co. (U.S.)
• Laboratory Corporation of America Holdings (U.S.)
• Fresenius Medical Care AG and Co. KGaA (Germany)
• QIAGEN (Germany)
• Quest Diagnostics Incorporated (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Tulip Diagnostics (P) Ltd. (India)
• Sonic Healthcare Limited (Australia)
• Merck KGaA (Germany)

SKU-50620